Scientific Program | ||||
Stream 1 | Stream 2 | Stream 3 | Stream 4 | Stream 5 |
Stream 3: Breaking Preclinical and Clinical Research |
Stream 3-1: Novel Targets Discovery |
Session 342: Drug Safety, Pharmacovigilance, Risk Management and Legal Aspects |
|
Day 3: Morning, Saturday, July 27, 2019 Place: Room G, 1st Floor |
|
Chair: Dr. Mircea Ciuca, Global Therapeutic Area Head, Global Clinical Safety and Pharmacovigilance, CSL Behring, Switzerland |
|
Time | Speeches and Speakers |
10:20-10:25 |
Chair’s Introduction |
10:25-10:45 | Title: Benefits of Structured Signal Management in Clinical Development Dr. Mircea Ciuca, Global Therapeutic Area Head, Global Clinical Safety and Pharmacovigilance, CSL Behring, Switzerland |
10:45-11:05 |
Title: Perception of Recreational Drugs Moderates the Relationship between Depressive Symptoms and Substance Use: Findings from a Nation-wide Survey in Taiwan |
11:05-11:25 |
Keynote Speech |
11:25-11:45 |
Title: What about Indigenous African Medicines in the Age of Biobetters? Dr. Mandla S Makhanya, Professor, University of South Africa, South Africa |
11:45-12:05 |
Title: 3D Printing Techniques in the Pharmaceutical Sciences – Intellectual Property Issues Dr. Catherine Jewell, Partner, Beck Greener LLP; Visiting Lecturer, University College London, School of Pharmacy, UK |
12:05-12:25 | Panel Discussion |
© 2003-2019 All rights reserved by BITeomics |